Navigation Links
Artificial cornea offers better results for infants, some blind patients

Infants and adults who are blind due to a cloudy or damaged cornea are seeing some remarkable results thanks to a new version of an artificial implant that takes the place of the cornea, the clear covering of the eye that serves as our window on the world.

The results of operations involving the first infants and children in the world to receive the device, performed by physicians at the University of Rochester Eye Institute and a colleague at Johns Hopkins University, are being announced at the annual meeting of the American Academy of Ophthalmology in Las Vegas.

The results, though based on a small number of patients, point to a new option for dramatically improving the vision of a group of people for whom traditional cornea transplants usually fail. The new work, supported in part by Research to Prevent Blindness, mirrors similar success in adult patients that was reported by the Rochester team this summer.

The latest study involved a plastic device known as the Boston Keratoprosthesis, an artificial cornea used by just a few doctors in the world to treat children who can't see because their corneas are opaque. Usually the cornea serves as a clear window, but in some children, it's as if a dark, opaque shade has been pulled over that window due to conditions like glaucoma, congenital anomalies, or previous cornea surgeries.

In Las Vegas, Rochester doctors showed that the Boston device seems to be very effective in infants and children from six weeks to 13 years old, restoring vision and putting an end to long cycles of eye operations that dog many patients who have needed a cornea transplant.

The study included 17 children who collectively had been through more than 100 surgical procedures, including 39 traditional cornea transplants that had failed, before the latest implant. In the new study, two of the children received another type of artificial implant that failed, while 15 received the Boston device. All 15 of
'"/>

Source:University of Rochester Medical Center


Page: 1 2 3 4 5 6

Related biology news :

1. Ophthalmologists Use Artificial Silicon Retina Microchip To Treat Vision Loss
2. New Research Shows Artificial Light at Night Stimulates Breast Cancer Growth in Laboratory Mice
3. Artifical cornea lets woman blind 20 years see
4. Scientists characterize proteome of human cornea
5. Scientists discover why cornea is transparent and free of blood vessels, allowing vision
6. Study shows how herpes infects cornea, evades immune cells
7. Leading reason for corneal transplants comes into focus
8. An artificial cornea is in sight, thanks to biomimetic hydrogels
9. Protein offers way to stop microscopic parasites in their tracks
10. Gene silencing technique offers new strategy for treating, curing disease
11. Mosaic mouse technique offers a powerful new tool to study diseases and genetics

Post Your Comments:
(Date:11/5/2009)... , The National Association of Biology Teachers (...or of biological sciences at Naugatuck Valley Comm...th the 2009 Evolution Education Award during the N...be held 11-14 November 2009 in Denver, Colorado. ,... the American Institute of Biological Sciences,(A...
(Date:11/4/2009)... , Heavy traffic corridors in the cities of Long ...ant proportion of preventable childhood asthma, an...ons on the disease has likely been underestimated,...thern California (USC). , The study, which appe...of Public Health , estimated that nine percent of ...
(Date:11/4/2009)... , PORTOLA VALLEY, Calif., Oct. 19 /PRNewswir...nced molecular sensing and imaging devices which s...today that it has signed exclusive distribution de...and Sensors. The markets covered include Australi...urg (Benelux), Suriname, Italy, France, Spain, Por...
Breaking Biology News(10 mins):Biologists, educators recognize excellence in evolution education 2USC study finds big air pollution impacts on local communities 2Spectros Signs New International Distribution Deals 2Illinois Medical District Recognizes Officers of its District Security Group 47860 1Illinois Medical District Recognizes Officers of its District Security Group 47860 2Pharmaxis Announces Placement of 2447 Million and Share Purchase Plan 12459 1Pharmaxis Announces Placement of 2447 Million and Share Purchase Plan 12459 2Orlando Dermatology Aesthetic 26 Clinical 28ODAC 29 Conference Announces Its 2010 Event 47854 1Orlando Dermatology Aesthetic 26 Clinical 28ODAC 29 Conference Announces Its 2010 Event 47854 2
...ered that two microRNA (miRNA) molecules help cont...of B-cell chronic lymphocytic leukemia (B-CLL), th...r findings, published in the December 15 issue of ...ing as powerful regulators of gene expression in c... drug treatment, the investigators say. , In t...
...blem could be eliminated simply by dusting slag on...& Industry, the magazine of the SCI. , In the ...f damage annually. , Researcher David Cowen and...t applying slag to wheat growing in greenhouses ha...orporate the silica and express it as spiky struct...
... of plants to defend themselves by accumulating hi...me insects, and that such adaptation potentially e...ites may in turn evolve to deal with high levels o...zabeth Pilon-Smits of Colorado State University an...rnia, Berkeley, appear in the November 21st issue ...
Other Biology News:Pair of microRNA molecules controls major oncogene in most common leukemia 2New moth variety disarms plants guarded by selenium 2
(Date:11/9/2009)...a research industry first, allowing veterinary res...afety study data to be managed in one software app... NJ (PRWEB) November 9, 2009 -- Xybion Medical Sys...™ VM, an integrated enterprise software solu...d care of veterinary research subjects. Pristima&t...
(Date:11/8/2009)... Complete Genomics, a third-generation human genom...of a report in the journal Science describing it...nalysis of sequence data from three complete human...omes sequenced on the proof-of-principle genomic D...to $1,726 for 45x coverage for the samples describ...
(Date:11/6/2009)...tCall/ -- BioSpecifics Technologies Corp. (Nasdaq:...irst-in-class collagenase-based products, today an...r ended September 30, 2009. ,, "We were extrem...,s Arthritis Advisory Committee unanimously recomm...TM) for the treatment of Dupuytren,s disease, and ...
(Date:11/6/2009)...wire/ -- EUCODIS Bioscience, a company,developing,... for the,chemical industry announced today that it...dus, the leading biopharmaceutical company in Lati...Bioscience exclusive access - for the search,of en...ection of,psychrophilic bacteria strains and other...
Breaking Biology Technology:Xybion Unveils Pristima™ VM, an Integrated Enterprise Software Solution for Vivarium and Veterinary Care Management 2Complete Genomics publishes in Science on low-cost sequencing of 3 human genomes 2Reissue with Tables: BioSpecifics Technologies Corp. Reports Third Quarter 2009 Financial Results 2Reissue with Tables: BioSpecifics Technologies Corp. Reports Third Quarter 2009 Financial Results 3Reissue with Tables: BioSpecifics Technologies Corp. Reports Third Quarter 2009 Financial Results 4Reissue with Tables: BioSpecifics Technologies Corp. Reports Third Quarter 2009 Financial Results 5Reissue with Tables: BioSpecifics Technologies Corp. Reports Third Quarter 2009 Financial Results 6EUCODIS Bioscience to Explore Novel Enzymatic Activities in Antarctic Bacteria Library From Bio Sidus 2
...in Shipping Dronabinol Soft Gel Capsules Immediate...ical Companies, Inc. (NYSE: PRX ) today announced... Food and Drug Administration for its,Abbreviated ...sion of,Solvay Pharmaceutical,s Marinol(R), a CIII... treat nausea and vomiting associated with cancer,...
...alif., June 30 As most doctors face the,Congressi...s next week,Arcadian Health Plan, Inc. announced t...network physicians at the same level of payment as...o supporting its physician,partners as they contin...,members., Arcadian recognizes the value and qual...
...H, Mass. June 30 Joseph B. Bolen, Ph.D., CSO,of M... Cancer track IBC,Life Sciences Drug Discovery & D...nd Exhibition taking place August 4-7 at the World.... The cancer track presentations will,focus on the...ncers, and,Clinical Biomarkers., Bolen has confir...
Other Biology Technology:Par Pharmaceutical Receives Final Approval to Market Generic Marinol(R) CIII (Dronabinol) Capsules 2Par Pharmaceutical Receives Final Approval to Market Generic Marinol(R) CIII (Dronabinol) Capsules 3Joseph B. Bolen, Ph.D. from Millennium to Conference Chair Cancer Sessions at IBC's Drug Discovery & Development of Innovative Therapeutics Conference 2
...ystem - dUTP with CyScribe GFX Purification Kit, 5...f Cy3- and Cy5-labeled cDNA.Optimized reagents are...purification.Flexible and optimized protocols can ...her Cy3- or Cy5-labeled nucleotides.Reliable purif...
Canine serum from Equitech-Bio
Rabbit Anti-TOLLIP Polyclonal Antibody, Unconjugated from Proteintech Group, Inc.
... mA, 100 W maximum.Constant voltage, constant curr...ts in settings and read-outs for precision and rep...tstanding choice for non-IEF ultrathin flatbed gel...Electrophoresis Systems & Standards & Reagents, Po...
Biology Products: